Surging Demand for Non-Pharmacological Therapies and Advancements in Neurostimulation Technologies Fuel Market Expansion ...

Nalu Medical, Inc. ("Nalu") announced today the appointment of Raymond W. Cohen to serve as chairman of its board of directors. Raymond Cohen served as the chief executive officer and member of the ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Segmentation Analysis Highlighted with 97 tables and 100 figures, this 190-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, Technology, ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

The Telangana Assembly on March 18 passed a Bill for the sub-categorisation of Scheduled Castes (SCs) for fair distribution of reservation as per the order passed by the Supreme Court last year.

The following is a summary of “An Evidence-Based Consensus for the Use of Neurostimulation for the Treatment of ... has gained support for spinal cord stimulation (SCS) in non-surgical low back pain ...

which was marketed for a rare form of blindness and implanted in hundreds of patients Cortigent’s precision neurostimulation technology is also being developed for the recovery of arm and hand ...

Reserve your spot now. The company highlights a significant interest in neurostimulation technology, driven in part by companies like Elon Musk's Neuralink. The global neurostimulation market is ...

A 24-month study compared CMM alone versus Nevro’s high-frequency (10 kHz) spinal cord stimulation (SCS) system for treating NSRBP. In April 2024, Medtronic plc, a world leader in medical technology, ...

Sooma Oy secured U.S. FDA investigational device exemption approval to initiate a pivotal study of its transcranial direct current stimulation medical device in people with major depressive disorder.